| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 365.58B | 396.03B | 366.81B | 401.63B | 339.76B | 323.75B |
| Gross Profit | 43.20B | 54.28B | 44.11B | 40.79B | 33.72B | 43.77B |
| EBITDA | 24.09B | 33.10B | 25.56B | 22.52B | 16.59B | 27.42B |
| Net Income | 15.96B | 24.07B | 17.54B | 12.39B | 9.65B | 15.10B |
Balance Sheet | ||||||
| Total Assets | 603.27B | 686.01B | 592.05B | 579.62B | 513.62B | 477.61B |
| Cash, Cash Equivalents and Short-Term Investments | 90.89B | 48.27B | 43.42B | 56.53B | 53.73B | 47.12B |
| Total Debt | 235.49B | 202.83B | 214.28B | 187.16B | 169.41B | 161.08B |
| Total Liabilities | 426.81B | 481.59B | 410.85B | 402.76B | 357.47B | 319.89B |
| Stockholders Equity | 167.91B | 194.90B | 172.14B | 168.82B | 148.84B | 151.33B |
Cash Flow | ||||||
| Free Cash Flow | -17.45B | -20.30B | -18.17B | 17.30B | 8.70B | 11.41B |
| Operating Cash Flow | -13.28B | 3.04B | 5.89B | 32.04B | 34.75B | 41.24B |
| Investing Cash Flow | -6.63B | -7.46B | -36.21B | -41.82B | -27.40B | -17.73B |
| Financing Cash Flow | 20.45B | 7.98B | 16.09B | 11.08B | -2.42B | -20.87B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥459.42B | 12.58 | ― | 2.73% | 10.07% | 47.19% | |
68 Neutral | ¥318.45B | 9.50 | 16.55% | 4.26% | 3.40% | 12.42% | |
67 Neutral | ¥499.74B | 13.92 | 10.95% | 1.88% | 9.18% | 184.84% | |
66 Neutral | ¥247.30B | 12.21 | 7.62% | 3.44% | -2.18% | 114.64% | |
65 Neutral | ¥213.85B | 8.91 | ― | 3.82% | 7.97% | 37.15% | |
64 Neutral | ¥2.33T | 13.55 | 16.64% | 1.83% | -3.02% | 50.20% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |